Gene · 5603
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tri-Combination Antiretroviral Therapy Induces Dose- and Time-Dependent Disruption of Intestinal Epithelial Barrier Function and Repair Responses in Human T84 Cells. | J Xenobiot | 2026 | 42783603 | PubTator, text mining | PubMed |
| Expression and Localization of AKT1, MAPK13, STAT1 and TLR4 in Lung Tissues From Patients With Asthma, COPD and Asthma-COPD Overlap. | Arch Bronconeumol | 2026 | 42754503 | PubTator, text mining | PubMed |
| Thinking Outside the Binding Site: A Self-Encapsulating Kinase Inhibitor Remodels Its Pocket to Achieve Selectivity. | Angew Chem Int Ed Engl | 2026 | 42745179 | PubTator, text mining | PubMed |
| Comparative Phytochemical and Antiviral Characteristics of Dipsacus asperoides and Phlomis umbrosa Against Influenza A Virus: LC-QTOF-MS Profiling and Exploratory Network Pharmacology. | Plants (Basel) | 2026 | 42739416 | PubTator, text mining | PubMed |
| Association between HOMA-IR and coexisting MASLD and type 2 diabetes: Insights from NHANES and network pharmacology. | Ther Adv Endocrinol Metab | 2026 | 42719461 | PubTator, text mining | PubMed |
| Unveiling the neurodevelopmental toxicity of PFOA and PFOS: evidence from integration of in silico and in vitro study. | Toxicol Mech Methods | 2026 | 42634987 | PubTator, text mining | PubMed |
| A TMED3-governed disulfidptosis-related diagnostic signature reveals tumor microenvironment remodeling in intrahepatic cholangiocarcinoma. | Front Immunol | 2026 | 42591673 | PubTator, text mining | PubMed |
| Exosomal lncRNA PVT1 promotes fibroblast activation and colon cancer progression via miR-23b-5p signaling. | J Pathol | 2026 | 42535319 | PubTator, text mining | PubMed |
| A Network Pharmacology Review of Plant-Derived Anticancer Compounds in Lung, Breast, Colorectal and Prostate Cancer. | Int J Mol Sci | 2026 | 42511521 | PubTator, text mining | PubMed |
| Integrative analysis identifies candidate biomarkers for bladder cancer: evidence from genomic and clinical validation. | Mol Biol Rep | 2026 | 42470583 | PubTator, text mining | PubMed |
| Discrete On-DNA Screening: A Frontier for Rapid Hit-to-Lead Optimization Applied to p38α. | ACS Med Chem Lett | 2026 | 42445005 | PubTator, text mining | PubMed |
| Clinical and Functional Significance of p38δ (MAPK13) in Lung Cancer. | Cancer Genomics Proteomics | 2026 | 42373225 | PubTator, text mining | PubMed |
| Floridoside as a Hinge-Targeted Inhibitor of MAPK13: Atomistic Insights from Molecular Dynamics Simulations. | Mar Drugs | 2026 | 42346777 | PubTator, text mining | PubMed |
| Facile synthesis of (4-phenylthiophen-2-yl)methyl 1-naphthoates via Suzuki-Miyaura cross-coupling: anti-seizure evaluation through molecular docking, EEG analysis, and ADMET profiling. | RSC Adv | 2026 | 42181711 | PubTator, text mining | PubMed |
| Identification of ribosomal stress related signature genes and immune microenvironment analysis in ovarian cancer based on multi-machine learning. | Discov Oncol | 2026 | 42113349 | PubTator, text mining | PubMed |
A natural defense against particulate matter 10 (PM10): Network pharmacology-based insights into the protective effects of Chrysanthemum zawadskii var. latilobum against PM10-induced lung inflammation. | Ecotoxicol Environ Saf | 2026 | 41985279 | PubTator, text mining | PubMed |
| Lenvatinib Promotes Metabolic Reprogramming Through RTK to Inhibit Hepatocellular Carcinoma Proliferation and Metastasis. | Hepatol Res | 2026 | 41979206 | PubTator, text mining | PubMed |
| Repurposing rosmarinic acid as an anti-colorectal cancer agent through bolstering T cell anti-tumor immunity by enhancing activation of MEK1-mediated TCR signaling. | Cancer Immunol Immunother | 2026 | 41925912 | PubTator, text mining | PubMed |
| Low, plasma level‑informed native curcumin concentrations fail to induce cell death in human lung and colorectal cancer cells. | Pharm Biol | 2026 | 41858052 | PubTator, text mining | PubMed |
| Early Development of Ocadusertib, a Selective Receptor-Interacting Serine/Threonine-Protein Kinase 1 Inhibitor. | Clin Transl Sci | 2026 | 41792865 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5603/papers